AI藥物研發公司Chai Discovery完成1.3億美元B輪融資，投後估值達13億美元，成爲獨角獸企業。本輪融資由General Catalyst和Oak HC/FT領投，老股東持續加碼，並引入新投資者。
Chai Discovery 完成1.3億美元B輪融資，估值達13億美元，由General Catalyst和Oak HC/FT領投，多家知名投資機構參與。公司總融資額超2.25億美元，專注於藥物發現領域，行業正逐步認識到人工智能在藥物研發中的潛力。
Chai Discovery完成1.3億美元B輪融資，估值達13億美元，由General Catalyst和Oak HC/FT領投，Menlo Ventures、OpenAI等多家知名機構參與，鞏固了其在AI藥物研發領域的領先地位。
18歲Tyler Rose與19歲Navvye Anand創立的Bindwell完成600萬美元種子輪融資，由General Catalyst與A Capital領投，Paul Graham跟投。公司放棄銷售AI工具，轉向自研農藥分子並授權，將藥物發現中的靶點設計引入農藥研發。其AI系統可在6小時內掃描全化合物庫，利用Foldwell結構預測等技術加速開發。估值未公開。
Xai
$2.1
輸入tokens/百萬
$3.5
輸出tokens/百萬
128
上下文長度
%20--%3e%3cdefs%3e%3cstyle%3e%20.st0%20{%20fill:%20%23061b40;%20}%20.st1%20{%20fill:%20%23306af1;%20}%20.st2%20{%20fill:%20%235ce5cf;%20}%20%3c/style%3e%3c/defs%3e%3cg%3e%3cpath%20class='st0'%20d='M55,10.5h9v3h-9v9h12V7.5h-12v3ZM64,19.5h-6v-3h6v3Z'/%3e%3cpolygon%20class='st0'%20points='69%2016.5%2078%2016.5%2078%2019.5%2069%2019.5%2069%2022.5%2081%2022.5%2081%2013.5%2072%2013.5%2072%2010.5%2081%2010.5%2081%207.5%2069%207.5%2069%2016.5'/%3e%3cpolygon%20class='st0'%20points='95%2010.5%2095%207.5%2083%207.5%2083%2022.5%2095%2022.5%2095%2019.5%2086%2019.5%2086%2016.5%2095%2016.5%2095%2013.5%2086%2013.5%2086%2010.5%2095%2010.5'/%3e%3cpath%20class='st0'%20d='M40,1.5v21h11.6l1.4-1.4v-7.6h0c0,0-1.4-1.5-1.4-1.5l1.4-1.4V2.9l-1.4-1.4h-11.6ZM50,19.5h-7v-6h7v6ZM50,10.5h-7v-6h7v6Z'/%3e%3c/g%3e%3cpath%20class='st1'%20d='M23.1,24L14.7,4.8l-4.9,11.2h3.8l-1.8,4H3.3L12.1,0H2C.9,0,0,.9,0,2v20c0,1.1.9,2,2,2h21.1Z'/%3e%3cpath%20class='st2'%20d='M34,0h-16.8l10.6,24h6.2c1.1,0,2-.9,2-2V2C36,.9,35.1,0,34,0ZM32.5,20h-4V4h4v16Z'/%3e%3c/svg%3e)
